Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Ardelyx Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
ARDX
Nasdaq
8731
https://www.ardelyx.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Ardelyx Inc
Ardelyx to Report First Quarter 2024 Financial Results on May 2, 2024
- Apr 18th, 2024 12:00 pm
The Millionaire’s Shortcut: 3 Stocks to Transform Your Portfolio This Month
- Apr 2nd, 2024 3:34 pm
Ardelyx, Inc. Reports Employment Inducement Grants
- Mar 28th, 2024 8:05 pm
Ardelyx Appoints Veteran BioPharma Executive, Mike Kelliher, as Executive Vice President, Corporate Development and Strategy
- Mar 25th, 2024 12:00 pm
Institutional investors may overlook Ardelyx, Inc.'s (NASDAQ:ARDX) recent US$195m market cap drop as long-term gains remain positive
- Mar 21st, 2024 2:38 pm
The Clock is Ticking: 3 Stocks Set to Explode in the Next Quarter
- Mar 16th, 2024 10:00 pm
The Millionaire’s Watchlist: 3 Stocks Set for a Meteoric Rise
- Feb 28th, 2024 10:40 pm
Ardelyx to Participate at the Cowen 44th Annual Health Care Conference
- Feb 27th, 2024 1:00 pm
Stocks on the Launchpad: The Next 3 Market Sensations
- Feb 27th, 2024 11:10 am
Ardelyx, Inc. (NASDAQ:ARDX) Q4 2023 Earnings Call Transcript
- Feb 23rd, 2024 3:16 pm
Ardelyx (ARDX) Reports Q4 Earnings: What Key Metrics Have to Say
- Feb 22nd, 2024 11:00 pm
Ardelyx (ARDX) Reports Q4 Loss, Lags Revenue Estimates
- Feb 22nd, 2024 10:15 pm
Ardelyx Inc (ARDX) Reports Robust Revenue Growth and Strategic Advances in 2023
- Feb 22nd, 2024 9:45 pm
Ardelyx Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
- Feb 22nd, 2024 9:01 pm
Will Nektar Therapeutics (NKTR) Report Negative Q4 Earnings? What You Should Know
- Feb 20th, 2024 3:00 pm
Analyst Upgrades: 3 Stocks Predicted to Soar In Q2 2024
- Feb 19th, 2024 8:30 pm
3 Revolutionary Biotech Stocks Poised for 10X Surge
- Feb 19th, 2024 5:24 pm
Ardelyx (ARDX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
- Feb 15th, 2024 3:00 pm
Wall Street Analysts Believe Ardelyx (ARDX) Could Rally 34.84%: Here's is How to Trade
- Feb 9th, 2024 2:55 pm
Ardelyx (ARDX) Is a Great Choice for 'Trend' Investors, Here's Why
- Feb 9th, 2024 1:50 pm
Scroll